Khosla Ventures, VCs Plow $100 Million Into Blood Test Startup Using AI
May 02, 2024 - bloomberg.com
Blood-testing firm Karius Inc. has secured $100 million in a recent funding round. The funds will be used to expand the reach of its technology, which is used to detect difficult-to-identify infections, into more hospitals.
The funding round was spearheaded by Khosla Ventures, an existing investor, in conjunction with 5AM Ventures and Glide Healthcare. Karius Inc. has not disclosed its valuation.
Key takeaways:
Blood-testing company Karius Inc. has raised $100 million in a new funding round.
The funding will be used to expand the reach of its technology for detecting hard-to-identify infections into more hospitals.
The funding round was led by existing investor Khosla Ventures, with participation from 5AM Ventures and Glide Healthcare.
